Assenagon Asset Management S.A. Vertex Pharmaceuticals Inc Transaction History

Assenagon Asset Management S.A.

  • $64.4 Billion
  • Q4 2025

A detailed history of Assenagon Asset Management S.A. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 832,853 shares of VRTX stock, worth $361 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
832,853
Previous 763,703 9.05%
Holding current value
$361 Million
Previous $299 Million 20.86%
% of portfolio
0.56%
Previous 0.46%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 09, 2026
BUY
$402.9 - $437.15 $27.9 Million - $30.2 Million
69,150 Added 9.05%
832,853 $361 Million
Q3 2025

Oct 07, 2025
BUY
$366.54 - $479.53 $191 Million - $250 Million
520,949 Added 214.6%
763,703 $299 Million
Q2 2025

Jul 11, 2025
BUY
$421.16 - $509.5 $14.6 Million - $17.6 Million
34,614 Added 16.63%
242,754 $108 Million
Q1 2025

Apr 15, 2025
SELL
$402.49 - $513.76 $254 Million - $324 Million
-631,532 Reduced 75.21%
208,140 $101 Million
Q4 2024

Jan 14, 2025
BUY
$396.64 - $516.74 $209 Million - $273 Million
528,029 Added 169.43%
839,672 $338 Million
Q3 2024

Oct 23, 2024
BUY
$460.0 - $505.78 $99.1 Million - $109 Million
215,448 Added 223.97%
311,643 $145 Million
Q2 2024

Jul 18, 2024
SELL
$392.81 - $485.53 $89.1 Million - $110 Million
-226,893 Reduced 70.23%
96,195 $45.1 Million
Q1 2024

Apr 24, 2024
BUY
$407.69 - $446.08 $11 Million - $12 Million
26,935 Added 9.09%
323,088 $135 Million
Q4 2023

Jan 17, 2024
BUY
$343.0 - $410.68 $32.2 Million - $38.6 Million
93,922 Added 46.44%
296,153 $121 Million
Q3 2023

Nov 06, 2023
SELL
$338.18 - $362.46 $61.7 Million - $66.1 Million
-182,487 Reduced 47.43%
202,231 $70.3 Million
Q2 2023

Jul 25, 2023
SELL
$314.42 - $351.91 $73.6 Million - $82.4 Million
-234,078 Reduced 37.83%
384,718 $135 Million
Q1 2023

Apr 18, 2023
SELL
$283.23 - $323.1 $34 Million - $38.8 Million
-120,191 Reduced 16.26%
618,796 $195 Million
Q4 2022

Jan 12, 2023
BUY
$285.76 - $321.48 $21.9 Million - $24.7 Million
76,752 Added 11.59%
738,987 $213 Million
Q3 2022

Oct 27, 2022
BUY
$273.83 - $305.53 $40 Million - $44.7 Million
146,237 Added 28.34%
662,235 $192 Million
Q2 2022

Jul 27, 2022
SELL
$234.96 - $292.55 $68.7 Million - $85.6 Million
-292,556 Reduced 36.18%
515,998 $145 Million
Q1 2022

Apr 25, 2022
BUY
$221.42 - $260.97 $108 Million - $127 Million
486,323 Added 150.92%
808,554 $211 Million
Q4 2021

Feb 01, 2022
BUY
$177.01 - $223.45 $44.7 Million - $56.5 Million
252,752 Added 363.78%
322,231 $70.8 Million
Q3 2021

Oct 19, 2021
SELL
$181.39 - $202.99 $30.2 Million - $33.8 Million
-166,649 Reduced 70.58%
69,479 $12.6 Million
Q2 2021

Jul 15, 2021
SELL
$187.49 - $221.1 $7.06 Million - $8.32 Million
-37,631 Reduced 13.75%
236,128 $47.6 Million
Q1 2021

Apr 26, 2021
SELL
$207.02 - $241.31 $67.2 Million - $78.4 Million
-324,687 Reduced 54.26%
273,759 $58.8 Million
Q4 2020

Feb 01, 2021
BUY
$207.01 - $276.09 $98.1 Million - $131 Million
474,130 Added 381.39%
598,446 $141 Million
Q3 2020

Oct 07, 2020
SELL
$255.65 - $303.1 $335,924 - $398,273
-1,314 Reduced 1.05%
124,316 $33.8 Million
Q2 2020

Jul 21, 2020
SELL
$225.48 - $295.8 $145 Million - $190 Million
-641,941 Reduced 83.63%
125,630 $36.5 Million
Q1 2020

Apr 17, 2020
BUY
$199.77 - $247.81 $99.5 Million - $123 Million
498,163 Added 184.91%
767,571 $183 Million
Q4 2019

Jan 17, 2020
BUY
$166.71 - $223.91 $40.1 Million - $53.9 Million
240,816 Added 842.25%
269,408 $59 Million
Q3 2019

Oct 16, 2019
BUY
$166.23 - $187.09 $3.21 Million - $3.62 Million
19,333 Added 208.8%
28,592 $4.84 Million
Q2 2019

Aug 12, 2019
SELL
$164.61 - $190.37 $9.76 Million - $11.3 Million
-59,305 Reduced 86.5%
9,259 $1.7 Million
Q1 2019

Apr 26, 2019
SELL
$163.73 - $194.7 $51.6 Million - $61.4 Million
-315,198 Reduced 82.13%
68,564 $12.6 Million
Q4 2018

Jan 23, 2019
BUY
$151.91 - $192.21 $29.2 Million - $37 Million
192,494 Added 100.64%
383,762 $63.6 Million
Q3 2018

Oct 29, 2018
SELL
$167.73 - $192.74 $29.1 Million - $33.4 Million
-173,500 Reduced 47.56%
191,268 $36.9 Million
Q2 2018

Jul 17, 2018
BUY
$145.72 - $169.96 $31 Million - $36.1 Million
212,481 Added 139.53%
364,768 $62 Million
Q1 2018

Apr 30, 2018
SELL
$151.6 - $177.13 $953,109 - $1.11 Million
-6,287 Reduced 3.96%
152,287 $24.8 Million
Q4 2017

Jan 25, 2018
SELL
$137.28 - $155.55 $101 Million - $114 Million
-734,806 Reduced 82.25%
158,574 $23.8 Million
Q3 2017

Oct 18, 2017
BUY
$148.13 - $162.24 $132 Million - $145 Million
893,380
893,380 $136 Million

Others Institutions Holding VRTX

# of Institutions
1,812
Shares Held
231M
Call Options Held
1.83M
Put Options Held
1.21M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $111B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email